PT  - JOURNAL ARTICLE
AU  - Wolfgang Zwickenpflug
AU  - Stefan Tyroller
AU  - Elmar Richter
TI  - METABOLISM OF MYOSMINE IN WISTAR RATS
AID  - 10.1124/dmd.104.003087
DP  - 2005 Nov 01
TA  - Drug Metabolism and Disposition
PG  - 1648--1656
VI  - 33
IP  - 11
4099  - http://dmd.aspetjournals.org/content/33/11/1648.short
4100  - http://dmd.aspetjournals.org/content/33/11/1648.full
SO  - Drug Metab Dispos2005 Nov 01; 33
AB  - The alkaloid myosmine is present not only in tobacco products but also in various foods. Myosmine is easily nitrosated, yielding 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) and the esophageal tobacco carcinogen N′-nitrosonornicotine. Due to its widespread occurrence, investigations on the metabolism and activation of myosmine are needed for risk assessment. Therefore, the metabolism of myosmine has been studied in Wistar rats treated with single oral doses of [pyridine-5-3H]myosmine at 0.001, 0.005, 0.5, and 50 μmol/kg body weight. Oral administration was achieved by feeding a labeled apple bite. Radioactivity was completely recovered in urine and feces within 48 h. At the two lower doses, 0.001 and 0.005 μmol/kg, a higher percentage of the radioactivity was excreted in urine (86.2 ± 4.9% and 88.9 ± 1.7%) as compared with the higher doses, 0.5 and 50 μmol/kg, where only 77.8 ± 7.3% and 75.4 ± 6.6% of the dose was found in urine. Within 24 h, urinary excretion of radioactivity was nearly complete with less than 4% of the total urinary output appearing between 24 and 48 h. The two major metabolites accounting for >70% of total radioactivity in urine were identified as 3-pyridylacetic acid (20–26%) and 4-oxo-4-(3-pyridyl)butyric acid (keto acid, 50–63%) using UV-diode array detection and gas chromatography-mass spectrometry measurements. 3-Pyridylmethanol (3–5%), 3′-hydroxymyosmine (2%) and HPB (1–3%) were detected as minor metabolites. 3′-Hydroxymyosmine is exclusively formed from myosmine and therefore might be used as a urinary biomarker for myosmine exposure in the future. The American Society for Pharmacology and Experimental Therapeutics